Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers

Neuroradiology

Volumn 54, Issue 3, 2012, Pages 205-213

  Awasthi, Rishi ^a   Rathore, Ram K S ^b   Soni, Priyanka ^b,c   Sahoo, Prativa ^b   Awasthi, Ashish ^a   Husain, Nuzhat ^c   Behari, Sanjay ^a   Singh, Rohit K ^a   Pandey, Chandra M ^a   Gupta, Rakesh K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^c UNIVERSITY OF LUCKNOW   (India)

Author keywords

Dynamic contrast enhanced MRI; HIF 1 expression; MMP 9 expression; PRL 3 expression; VEGF expression

Indexed keywords

CELL PROTEIN; GADODIAMIDE; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATASE OF REGENERATING LIVER 3 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; HIF1A PROTEIN, HUMAN; PROTEIN TYROSINE PHOSPHATASE; PTP4A3 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN; VASCULOTROPIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CANCER GRADING; CANCER TISSUE; CONTRAST ENHANCEMENT; DISCRIMINANT ANALYSIS; FEMALE; GLIOBLASTOMA; GLIOMA; GLIOSARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TREATMENT PLANNING; BLOOD VOLUME; BRAIN CIRCULATION; BRAIN TUMOR; ENZYME IMMUNOASSAY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; VASCULARIZATION;

ADOLESCENT; ADULT; AGED; BLOOD VOLUME; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DISCRIMINANT ANALYSIS; FEMALE; GLIOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; MAGNETIC RESONANCE IMAGING; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM PROTEINS; PREDICTIVE VALUE OF TESTS; PROTEIN TYROSINE PHOSPHATASES; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84862315744     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-011-0874-y     Document Type: Article

References (35)

1. Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97-109 (Pubitemid 47103521)
2. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P (1998) Grading of astrocytomas. A simple and reproducible method. Cancer 62(10):2152-2165
3. Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low grade) astrocytoma. J Neurosurg 79 (4):533-536 (Pubitemid 23289810)
4. Petrella JR, Provenzale JM (2000) MR perfusion imaging of the brain: techniques and applications. Am J Roentgenol 175(1):207-219 (Pubitemid 30415566)
5. Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191(1):41-51
6. Cha S, Knopp EA, Johnson G et al (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echoplanar perfusion MR imaging. Radiology 223(1):11-29 (Pubitemid 34258186)
7. Pauliah M, Saxena V, Haris M, Husain N, Rathore RK, Gupta RK (2007) Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma. Magn Reson Imaging 25(9):1292-1299 (Pubitemid 47625925)
8. Singh A, Haris M, Rathore D, Purwar A et al (2007) Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26(4):871-880 (Pubitemid 47548145)
9. Haris M, Gupta RK, Singh A et al (2008) Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI. Neuroradiology 50(6):531-540 (Pubitemid 351763583)
10. Haris M, Kumar S, Raj MK et al (2008) Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas. Radiat Med 26(3):140-150 (Pubitemid 351652565)
11. Awasthi R, Verma SK, Haris M, Singh A, Behari S, Jaiswal AK (2010) Comparative evaluation of dynamic contrast-enhanced perfusion with diffusion tensor imaging metrics in assessment of corticospinal tract infiltration in malignant glioma. J Comput Assist Tomogr 34(1):82-88
12. Ferrara N, Devis-Smith T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18(1):4-25 (Pubitemid 27076453)
13. Veikkola T, Alitalo K (1999) VEGFs, receptors and angiogenesis. Semin Cancer Biol 9(3):211-220 (Pubitemid 29273837)
14. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM (1998) Stabilization of wild-type p53 by hypoxia-inducible factor-1 alpha. Nature 392(6674):405-408
15. Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L (1998) p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273(20):11995-11998 (Pubitemid 28240554)
16. VanMeter TE, Rooprai HK, Kibble MM et al (2001) The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol 53(2):213-235 (Pubitemid 33034693)
17. Levicar N, Nuttall RK, Lah TT (2003) Proteases in brain tumour progression. Acta Neurochir Wien 145(9):825-838 (Pubitemid 37204559)
18. Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3(7):489-01
19. Yong VW (2005) Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6(12):931-944 (Pubitemid 41753087)
20. Forsyth PA, Wong H, Laing TD et al (1999) Gelatinase - A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79(11-12):1828-1835 (Pubitemid 29132312)
21. Jadhav U, Chigurupati S, Lakka SS, Mohanam S (2004) Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 25(5):1407-1414
22. Liang F, Luo Y, Dong Y et al (2008) Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase. J Biol Chem 283(16):10339-10346
23. Saha S, Bardelli A, Buckhaults P et al (2001) A phosphatase associated with metastasis of colorectal cancer. Science 294 (5545):1343-1346 (Pubitemid 33063101)
24. Wu X, Zeng H, Zhang X et al (2004) Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 164(6):2039-2054 (Pubitemid 38669352)
25. Parker BS, Argani P, Cook BP et al (2004) Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res 64 (21):7857-7866 (Pubitemid 39446919)
26. Kong L, Li Q, Wang L, Liu Z, Sun T (2007) The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas. Neuropathology 27(6):516-521 (Pubitemid 350045676)
27. Singh A, Haris M, Rathore D et al (2007) Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26(4):871-880 (Pubitemid 47548145)
28. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249-257
29. Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (5302):964-967 (Pubitemid 27087709)
30. Kassner A, Thornhill R (2011) Measuring the integrity of the human blood-brain barrier using magnetic resonance imaging. Meth Mol Biol 686:229-245
31. Vidarsson L, Thornhill RE, Liu F, Mikulis DJ, Kassner A (2009) Quantitative permeability magnetic resonance imaging in acute ischemic stroke: how long do we need to scan? Magn Reson Imaging 27(9):1216-1222
32. Haris M, Husain N, Singh A et al (2008) Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma. J Comput Assist Tomogr 32(6):955-965
33. Cher LM, Murone C, Lawrentschuk N et al (2006) Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med 47(3):410-418 (Pubitemid 46768482)
34. Alvarez JI, Teale JM (2007) Evidence for differential changes of junctional complex proteins in murine neurocysticerosis dependent upon CNS vasculature. Brain Res 1169:98-111 (Pubitemid 47374095)
35. Zhao Y, Xiao A, diPierro CG et al (2010) An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9. Am J Pathol 176(6):3032-3049